fb-pixel Skip to main content

Latest Headlines in Biotech


A Hologic mammogram machine.

Hologic to acquire European diagnostics company for $795 million

The Marlborough-based medical tech company has been growing through acquisitions. Already this year, Hologic has bought two other diagnostics firms for nearly $390 million combined.

MIT professor and entrepreneur Sangeeta Bhatia.

MIT scientists launch Future Founders Initiative to help solve biotech’s ‘missing women’ problem

The Boston Biotech Working Group released a report that shows male faculty at MIT start companies at a higher rate than their female peers, and it outlines an action plan to close the gap.

Food and Drug Administration headquarters in White Oak, Md.

FDA has been giving a green light to Massachusetts biotechs

Five companies have won approvals from the agency in recent weeks.

Nurse Samantha Schuko prepares a dose of the Moderna vaccine at Gillette Stadium in Foxborough.

Moderna wants to add doses to its vials to speed COVID-19 vaccinations

As Moderna approaches its daily production benchmark of 1 million doses, the company’s president, Stephen Hoge, wants to increase the contents of each vial to 15 doses to relieve “one of the manufacturing bottlenecks.”

Moderna's COVID-19 vaccine is currently restricted to people at least 18 years old.

Moderna says vaccine study in adolescents has picked up speed

The Cambridge company hopes to have results by the summer.

On STATnews.com
The world is waiting for the results of Moderna’s vaccine trial.

Selling stock like clockwork, Moderna’s top doctor gets $1 million richer every week

As the world awaits results from Moderna’s pivotal COVID-19 vaccine study, Chief Medical Officer Tal Zaks has been selling his existing stock like clockwork, earning him over $50 million since the dawn of the pandemic.

CureVac's global headquarters is in Tuebingen, Germany.

Stock price of German COVID-19 vaccine maker with US headquarters in Boston closes up nearly 250% in its debut

'This is kind of beyond expectations,' says CureVac's chief financial officer.

The headquarters of biotech company CureVac in Tuebingen, Germany.

Another potential COVID-19 vaccine with Boston ties to enter clinical trials

CureVac, a German firm with about 20 employees here, says it has permission to start testing in people.